Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Forecasting the patient's response to neoadjuvant chemoradiotherapy (nCRT) is crucial for managing locally advanced rectal cancer (LARC). This study investigates whether a predictive model using image-text features extracted from endorectal ultrasound (ERUS) via Contrastive Language-Image Pretraining (CLIP) can predict tumor regression grade (TRG) before nCRT.

Methods: A retrospective analysis of 577 LARC patients who received nCRT followed by surgery was conducted from January 2018 to December 2023. ERUS scans and TRG were used to assess nCRT response, categorizing patients into good (TRG 0) and poor (TRG 1-3) responders. Image and text features were extracted using the ResNet50+RBT3 (RN50) and ViT-B/16+RoBERTa-wwm (VB16) components of the Chinese-CLIP model. LightGBM was used for model construction and comparison. A subset of 100 patients from each responder group was used to compare the CLIP method with manual radiomics methods (logistic regression, support vector machines, and random forest). SHapley Additive exPlanations (SHAP) technique was used to analyze feature contributions.

Results: The RN50 and VB16 models achieved AUROC scores of 0.928 (95% CI: 0.90-0.96) and 0.900 (95% CI: 0.86-0.93), respectively, outperforming manual radiomics methods. SHAP analysis indicated that image features dominated the RN50 model, while both image and text features were significant in the VB16 model.

Conclusions: The CLIP-based predictive model using ERUS image-text features and LightGBM showed potential for improving personalized treatment strategies. However, this study is limited by its retrospective design and single-center data.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11633952PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0315339PLOS

Publication Analysis

Top Keywords

endorectal ultrasound
8
neoadjuvant chemoradiotherapy
8
locally advanced
8
advanced rectal
8
rectal cancer
8
predictive model
8
image-text features
8
features extracted
8
image text
8
text features
8

Similar Publications

Prognostic Value of Extramural Depth of Tumor Invasion to Thickness of Mesorectum Ratio at Pretreatment Endorectal Ultrasound in T3 Rectal Cancer Patients.

Ultrasound Med Biol

August 2025

Department of Medical Ultrasonics, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; Biomedical Innovation Center, The Sixth Af

Objective: To evaluate the prognostic value of the extramural depth (EMD)/thickness of mesorectum (TM) ratio in patients with cT3 rectal cancer (RC).

Methods: This study enrolled 382 treatment-naive cT3 RC patients undergoing endorectal ultrasound from January 2018 to January 2020. The last follow-up date was January 31, 2025.

View Article and Find Full Text PDF

Endorectal ultrasound (US)-guided thermal ablation of prostate cancer using high-intensity focused ultrasound (HIFU) is a widely used focal intervention. While generally safe and effective, it is not without challenges associated with heat diffusion and prefocal heating, which has spurred interest towards non-thermal, mechanical HIFU ablation regimes. Another challenge is the necessity to mechanically translate the HIFU transducer - commonly single-element or annular array - for volumetric treatments, which results in target shifts and transducer position readjustment.

View Article and Find Full Text PDF

Background: KRAS mutations are associated with treatment and prognostic outcomes in colorectal cancer patients.There have been no studies on utilizing the peritumoral images to predict KRAS mutation status in rectal cancer patients. We aim to develop a radiomics model utilizing intratumoral and peritumoral ultrasound images for predicting KRAS mutation status in rectal cancer.

View Article and Find Full Text PDF

Background: Timely and precise diagnosis of rectal tumors is pivotal for improving patient outcomes. Despite advances in imaging technologies, differentiating benign adenomas from early-stage rectal cancer remains a significant challenge. The aim of this study was to assess the effectiveness of endorectal ultrasound (ERUS) elastography in differentiating rectal adenomas from cancer.

View Article and Find Full Text PDF

Background: Endorectal ultrasound (ERUS) and magnetic resonance imaging (MRI) are key diagnostic tools for rectal cancer staging. ERUS is preferred for early-stage cancer, while MRI is the standard for advanced stages. However, their effectiveness in patients undergoing neoadjuvant therapy (NAT) remains debated.

View Article and Find Full Text PDF